|
⚲
|
| Tetraphase Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001373707 |
| Sale | 2009-09-11 ($29.6 M Offered, $10.0 M Sold) |
| Fund | |
| Phone | 6177153600 |
| Address | 480 Arsenal Street Watertown, 02472 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Robert Weisskoff | |
| Guy Macdonald | |
| Lawrence Miller | |
| Karl Handelsman | |
| David Lubner | |
| Eric Gordon | |
| Douglas Cole |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Merrill Carolyn
✚
|
0.0 | |
|
Merrill Joanne
✚
|
0.0 | |
|
Merrill Mark G
✚
|
0.0 | |
|
Merriwether Cambrea R
✚
|
0.0 | |
|
Mesa AZ FF LLC
✚
|
0.0 | |
|
FC Investors XXI LLC
✚
|
0.0 | |
|
FCI TeraView, L.P.
✚
|
0.0 | |
|
FC/Kensington Co-Investment Fund LLC
✚
|
0.0 | |
|
FCL Capital, LLC
✚
|
0.0 | |
|
Bursic David J
✚
|
0.0 |